Several bioactive compounds modulate cytochrome P450 enzymes, particularly CYP3A4, CYP2D6, and CYP2C9, which are essential for the metabolism of chemotherapeutic agents and endocrine therapies
some payers reimburse only FDA-approved commercial versions, whereas others cover compounded prescriptions when medically justified and accompanied by documentation of a clinical need that cannot be met by a manufactured product
When levels fall low enough, oxidative stress accumulates, which is associated with fatigue, compromised immune response, accelerated skin aging, and increased strain on the liver
10.1080/00150193.2019.1592538 Ferroelectrics
The reclassification process involves rule-making, supply chain review, and public comment, which will take months at minimum